Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced on June 5 2025, that LUMRYZTM has been granted Orphan...
Robots and AI in Drug Discovery Are Transforming Medicine
Why Drug Discovery Needs Robots and Artificial Intelligence
The discovery of new drugs has been a staple of medical breakthroughs for years, fueling advancements in...
Stringent Policy around COVID Vaccines Laid by FDA
The US FDA is now tightening its regulatory policy around COVID vaccines by setting up a new framework that raises the bar for certain...
Pharmaceutical Chemicals Market Booms with Rising API Demand
The international pharmaceutical chemicals market is witnessing vibrant growth, driven by expanding demand for Active Pharmaceutical Ingredients (APIs) and specialty chemical innovations. The expression...
Next in Pharma 2025: Innovations Shaping the Future
The pharmaceutical sector stands at the threshold of a dramatic change with 2025 set to redefine the benchmarks in terms of innovation, efficiency, and...
Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk
In today's fast-paced laboratory environments, maintaining productivity while ensuring high-quality data capture is a critical challenge. Traditional lab informatics systems often require scientists and...
AI Revolutionizing Drug Discovery and Clinical Development
Artificial intelligence (AI) is no longer a solution to be theorized for drug discovery and clinical development, but rather a transformative tool that is changing...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...